Article
Polymorphism of the beta3-adrenergic receptor and lipid profile in patients with rheumatoid arthritis and systemic lupus erythematosus treated with chloroquine.
Rheumatology international - 1 May 2003
Muñoz-Valle J F, Vázquez-Del Mercado M, Ruiz-Quezada S, Oregón-Romero E, Navarro-Hernández R E, Ramírez-Barragán J, Martínez-Bonilla G, Bernard-Medina G, Bastidas-Ramírez B E, Ruiz-Madrigal B, Panduro A
Abstract excerpt
We investigated the effect of beta 3-adrenergic receptor (beta(3)AR) polymorphism on lipid profiles in patients with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) treated with chloroquine. One hundred sixty-eight subjects were classified into three groups: 61 RA patients, 57 SLE patients, and 50 healthy subjects. All patients fulfilled the 1987 and 1982 classification criteria for RA and SLE,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.